CH521373A - Verfahren zur Herstellung einer Cephalosporinverbindung - Google Patents

Verfahren zur Herstellung einer Cephalosporinverbindung

Info

Publication number
CH521373A
CH521373A CH625869A CH625869A CH521373A CH 521373 A CH521373 A CH 521373A CH 625869 A CH625869 A CH 625869A CH 625869 A CH625869 A CH 625869A CH 521373 A CH521373 A CH 521373A
Authority
CH
Switzerland
Prior art keywords
preparation
cephalosporin compound
cephalosporin
compound
Prior art date
Application number
CH625869A
Other languages
German (de)
English (en)
Inventor
Marvin Van Heyningen Earle
Lawrence Spencer John
Wilbur Ryan Charles
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH521373A publication Critical patent/CH521373A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24DDOMESTIC- OR SPACE-HEATING SYSTEMS, e.g. CENTRAL HEATING SYSTEMS; DOMESTIC HOT-WATER SUPPLY SYSTEMS; ELEMENTS OR COMPONENTS THEREFOR
    • F24D19/00Details

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Combustion & Propulsion (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermal Sciences (AREA)
  • Cephalosporin Compounds (AREA)
CH625869A 1968-04-25 1969-04-24 Verfahren zur Herstellung einer Cephalosporinverbindung CH521373A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72424668A 1968-04-25 1968-04-25

Publications (1)

Publication Number Publication Date
CH521373A true CH521373A (de) 1972-04-15

Family

ID=24909645

Family Applications (1)

Application Number Title Priority Date Filing Date
CH625869A CH521373A (de) 1968-04-25 1969-04-24 Verfahren zur Herstellung einer Cephalosporinverbindung

Country Status (9)

Country Link
US (1) US3459749A (enExample)
CH (1) CH521373A (enExample)
DE (1) DE1921206A1 (enExample)
DK (1) DK124757B (enExample)
FR (1) FR2007515A1 (enExample)
GB (1) GB1210489A (enExample)
IE (1) IE33115B1 (enExample)
IL (1) IL32035A (enExample)
NL (1) NL160488C (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2440268A1 (de) * 1974-08-22 1976-03-04 Bayer Ag Beta-lactamantibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157648A (en) * 1961-08-25 1964-11-17 Smith Kline French Lab Derivatives of 7-aminocephalo-sporanic acid
FR1524026A (fr) * 1963-03-27 1968-05-10 Glaxo Lab Ltd Dérivés de l'acide 7-aminocéphalosporanique et procédé pour leur préparation
FR1524027A (fr) * 1963-05-28 1968-05-10 Glaxo Lab Ltd Dérivés de l'acide 7-aminocéphalosporanique et leur procédé de préparation
US3382241A (en) * 1967-02-27 1968-05-07 Lilly Co Eli Certain orally active cephalosporin antibiotics

Also Published As

Publication number Publication date
DK124757B (da) 1972-11-20
IE33115B1 (en) 1974-03-20
DE1921206A1 (de) 1969-11-20
IL32035A (en) 1972-07-26
IE33115L (en) 1969-10-25
FR2007515A1 (enExample) 1970-01-09
GB1210489A (en) 1970-10-28
NL160488B (nl) 1979-06-15
NL6906146A (enExample) 1969-10-28
IL32035A0 (en) 1969-06-25
US3459749A (en) 1969-08-05
NL160488C (nl) 1979-11-15

Similar Documents

Publication Publication Date Title
CH506591A (de) Verfahren zur Herstellung von Monoazoverbindungen
CH475258A (de) Verfahren zur Herstellung einer Cytosinverbindung
AT291926B (de) Verfahren zur Herstellung einer Bindemittelsuspension
AT312798B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
CH517821A (de) Verfahren zur Herstellung einer Pigmentzubereitung
AT298671B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
CH499597A (de) Verfahren zur Herstellung von Azoverbindungen
CH523318A (de) Verfahren zur Herstellung einer therapeutisch wirksamen Verbindung
CH471861A (de) Verfahren zur Herstellung von Monoazoverbindungen
AT300192B (de) Verfahren zur Herstellung eines Penicillinpräparates
AT312165B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
CH504395A (de) Verfahren zur Herstellung einer Hydroxyindanverbindung
CH511925A (de) Verfahren zur Herstellung von Monoazoverbindungen
CH510086A (de) Verfahren zur Herstellung von Azoverbindungen
CH518972A (de) Verfahren zur Herstellung einer Chromenopyrazolverbindung
CH521373A (de) Verfahren zur Herstellung einer Cephalosporinverbindung
CH534694A (de) Verfahren zur Herstellung von 2-Cephemverbindungen
AT292730B (de) Verfahren zur Herstellung einer neuen Germaniumsäure-Cysteinverbindung
AT286497B (de) Verfahren zur Herstellung einer Vaccine
CH529169A (de) Verfahren zur Herstellung einer Organozinnverbindung
CH484091A (de) Verfahren zur Herstellung einer Sesquiterpenverbindung
AT293614B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH501039A (de) Verfahren zur Herstellung von basischen Monoazoverbindungen
AT296887B (de) Verfahren zur Herstellung einer Packung Vorrichtung zur Durchführung derselben
CH489573A (de) Verfahren zur Herstellung von Monoazoverbindungen

Legal Events

Date Code Title Description
PL Patent ceased